Portfolio company
ORISDX
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops non-invasive salivary diagnostic tests for early oral cancer detection, serving dentists, oncologists and primary care providers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Vigilant Biosciences
This company develops saliva-based point-of-care diagnostic tests for the early detection of oral cancer for clinicians and dental practices.
Infiniplex
This company develops liquid biopsy solutions using blood tests to monitor genetic biomarkers for cancer screening and precision oncology decisions for healthcare providers.
Glycanostics
This digital health company develops non-invasive liquid biopsy tests for early-stage cancer detection, serving clinical laboratories, hospitals and oncology professionals.
AnchorDx
This company develops non-invasive liquid biopsy tests and diagnostic tools for early cancer screening, diagnosis and recurrence monitoring for healthcare providers and patients.
CrescentDX
This company develops and markets diagnostic screening tests for osteoporosis and hip fracture risk assessment for medical physicians and healthcare providers.
Epiliquid
This company develops blood-based liquid biopsy tests for early cancer detection and monitoring, serving clinical laboratories and medical practitioners.
Oncoliq
This company develops liquid biopsy tests using molecular biology and machine learning for early cancer detection in clinical and screening settings.
Bristle Health
This company provides oral microbiome saliva tests and probiotics for consumers and dental practitioners to monitor and improve oral health.
